ODI PHARMA AB Tangible Net Worth Ratio
ODI PHARMA AB tangible net worth ratio. ODI PHARMA AB (6OD) has a Tangible Net Worth Ratio of 100.0% as of June 2026. This metric is calculated by deducting intangible assets (€0.00) from net assets (€2.38 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See ODI PHARMA AB net asset quality index to measure how much of total assets are equity-financed.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of ODI PHARMA AB (2022–2026)
Tangible net worth ratio of ODI PHARMA AB from 2022 to 2026. This chart shows how ODI PHARMA AB's Tangible Net Worth Ratio has changed across 5 annual periods from 2022 to 2026. As of June 2026, the ratio stands at 100.0%, reflecting net assets of €2.38 Million with intangible assets of €0.00 EUR. See 6OD working capital ratio to evaluate short-term liquidity relative to the company's equity base.
ODI PHARMA AB Tangible Net Worth Ratio by Year (2022–2026)
ODI PHARMA AB tangible net worth ratio by year from 2022 to 2026. The table below presents the year-by-year Tangible Net Worth Ratio for ODI PHARMA AB from 2022 to 2026, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see ODI PHARMA AB market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2026 | 100.0% | €2.38 Million | €0.00 | €5.30 Million | ▲ +0.0 pp |
| 2025 | 100.0% | €424.64K | €0.00 | €4.61 Million | ▲ +0.0 pp |
| 2024 | 100.0% | €2.00 Million | €0.00 | €12.23 Million | ▲ +0.0 pp |
| 2023 | 100.0% | €2.57 Million | €0.00 | €8.19 Million | ▲ +0.0 pp |
| 2022 | 100.0% | €9.26 Million | €0.00 | €10.50 Million | — |